Literature DB >> 11377314

Interexaminer reliability and validity of a three-dimensional model to assess prostate volume by digital rectal examination.

C G Roehrborn1, S Sech, J Montoya, T Rhodes, C J Girman.   

Abstract

OBJECTIVES: To evaluate the interexaminer reliability and accuracy compared with transrectal ultrasound (TRUS) of a three-dimensional (3D) model and other scales to improve the estimation of prostate volume by digital rectal examination (DRE).
METHODS: Volunteers from a urology clinic (n = 121) were examined independently by three examiners with different levels of experience in randomized order. During DRE, the examiners estimated the prostate size in increments of 5 g, using various rating scales and a 3D sizing model, without access to the findings of the other investigators. TRUS was then performed by each examiner.
RESULTS: The 121 volunteers were 39 to 82 years old, with a mean +/- SD total TRUS prostate size of 35.9 +/- 27.2 g. The DRE size estimates ranged from 15 to 100 g across all examiners and patients. The interexaminer reliability across examiners for the best DRE prostate size estimates (in grams) was 0.78 (95% confidence interval 0.70 to 0.84), and the correlation coefficients (r(s)) with the TRUS volume ranged from 0.61 to 0.72 for the three examiners. A 3D model showed good reliability (intraclass correlation coefficient 0.86, 95% confidence interval 0.75 to 0.93), and correlated well with the TRUS volume (r(s) = 0.67 to 0.75). Other scales showed fair reliability (0.58 to 0.68) and correlated with the TRUS measurements (0.57 to 0.67). The area under the receiver operating characteristic curve to identify prostate volumes greater than 40 g ranged from 0.78 to 0.90 for DRE estimates (in grams) and 0.69 to 0.89 for the 3D model.
CONCLUSIONS: DRE size estimates and TRUS volume were moderately to highly correlated in men without prostate cancer. A 3D sizing model showed comparable reliability and correlation with TRUS. Although the DRE estimates generally tend to underestimate the TRUS-measured prostate volume, these tools may be useful in identifying men with enlarged prostate glands.

Entities:  

Mesh:

Year:  2001        PMID: 11377314     DOI: 10.1016/s0090-4295(01)00965-7

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  10 in total

1.  [Parameters to improve the specificity of the prostate-specific antigen. Early detection of prostate cancer].

Authors:  C Börgermann; S Kliner; A Swoboda; H-J Luboldt; H Rübben
Journal:  Urologe A       Date:  2011-09       Impact factor: 0.639

2.  Shape analysis of the prostate: establishing imaging specifications for the design of a transurethral imaging device for prostate brachytherapy guidance.

Authors:  David R Holmes; Brian J Davis; Christopher C Goulet; Torrence M Wilson; Lance A Mynderse; Keith M Furutani; Jon J Camp; Richard A Robb
Journal:  Brachytherapy       Date:  2014-06-21       Impact factor: 2.362

Review 3.  Symptomatic diagnosis of prostate cancer in primary care: a structured review.

Authors:  William Hamilton; Deborah Sharp
Journal:  Br J Gen Pract       Date:  2004-08       Impact factor: 5.386

4.  Digital rectal examination standardization for inexperienced hands: teaching medical students.

Authors:  Leonardo Oliveira Reis; Antonio Felipe Leite Simão; Jamal Baracat; Fernandes Denardi; Antonio Gugliotta
Journal:  Adv Urol       Date:  2013-09-19

5.  Dichotomous estimation of prostate volume: a diagnostic study of the accuracy of the digital rectal examination.

Authors:  Michael Z Su; Daniel Lenaghan; Henry H Woo
Journal:  World J Mens Health       Date:  2013-12-24       Impact factor: 5.400

Review 6.  Korean clinical practice guideline for benign prostatic hyperplasia.

Authors:  Jeong Kyun Yeo; Hun Choi; Jae Hyun Bae; Jae Heon Kim; Seong Ok Yang; Chul Young Oh; Young Sam Cho; Kyoung Woo Kim; Hyung Ji Kim
Journal:  Investig Clin Urol       Date:  2016-01-11

7.  Observational study comparing the accuracy/variability between the ERSPC and the PCPT risk calculators for the prediction of significant prostate cancer in patients with PSA <10 ng/mL.

Authors:  Enrique Gomez Gomez; Juan José Salamanca Bustos; Julia Carrasco Valiente; Jose Luis Fernandez Rueda; Ana Blanca; José Valero Rosa; Ines Bravo Arrebola; Javier Marquez López; Juan Manuel Jimenez Vacas; Raul Luque; Maria José Requena Tapia
Journal:  BMJ Open       Date:  2019-11-12       Impact factor: 2.692

8.  Reliability and validity of assessment methods available in primary care for bladder outlet obstruction and benign prostatic obstruction in men with lower urinary tract symptoms: a systematic review.

Authors:  Tom Vredeveld; Esther van Benten; Rikie E P M Beekmans; M Patrick Koops; Johannes C F Ket; Jurgen Mollema; Stephan P J Ramaekers; Jan J M Pool; Michel W Coppieters; Annelies L Pool-Goudzwaard
Journal:  BMJ Open       Date:  2022-04-29       Impact factor: 3.006

9.  Factors affecting trial without catheter for first spontaneous acute urinary retention.

Authors:  Punit Mahadik; Surya Prakash Vaddi; Chandra-Mohan Godala; V Vijaya Kumar Reddy; Venkat Krishna Sambar
Journal:  Int Neurourol J       Date:  2013-09-30       Impact factor: 2.835

10.  Clinical correlates of enlarged prostate size in subjects with sexual dysfunction.

Authors:  Giovanni Corona; Mauro Gacci; Elisa Maseroli; Giulia Rastrelli; Linda Vignozzi; Alessandra Sforza; Gianni Forti; Edoardo Mannucci; Mario Maggi
Journal:  Asian J Androl       Date:  2014 Sep-Oct       Impact factor: 3.285

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.